Culture System for Isolating Circulating Tumor cells_2
NCT04125667 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 45
Last updated 2019-10-14
Summary
This culture system utilizes the special affinity difference of biomedical material coating for different cells to achieve the effect of isolating tumor cells from the blood sample. The coating of the system has the characteristic that to make the WBCs adhesion, but the cancer cells in the blood sample suspend in the culture medium, which achieves the effect of separating cancer cells from the blood. The supernatant with the cancer cells can further be isolated from the cultural system for related analysis and detection to achieve early diagnosis and screening.
Conditions
- Early Diagnosis
- Diagnostic Techniques and Procedures
Sponsors & Collaborators
-
National Taiwan University Hospital
lead OTHER
Principal Investigators
-
Tai-Horng Young · Institute of Biomedical Engineering, National Taiwan University
Eligibility
- Min Age
- 20 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-10-31
- Primary Completion
- 2020-08-31
- Completion
- 2020-08-31
Countries
- Taiwan
Study Locations
More Related Trials
-
Detection of Circulating Tumor Cells in Peripheral Blood From Healthy Volunteers and Patients With Cancer
NCT02904161 ·Status: COMPLETED
-
Establishment and Application of 3-Dimensional (3-D) Cell Culture Model of Clinical Circulating Tumor Cells (CTCs)
NCT05623748 ·Status: COMPLETED
-
Collection and Storage of Tissue and Blood Samples From Patients With Cancer
NCT02474160 ·Status: RECRUITING
-
Collection of Blood, Bone Marrow, Tumor, or Tissue Samples From Patients With Cancer to Study Drug Resistance
NCT00026663 ·Status: COMPLETED
-
Collection of Blood, Bone Marrow, Tumor or Tissue Samples
NCT00043615 ·Status: COMPLETED
-
Evaluation of Different Analysis Methods for Circulating Tumor Cells, Circulating Endothelial Cell, and Circulating Tumor DNA in Patient Followed for a Tumoral Pathology
NCT02220556 ·Status: COMPLETED ·Phase: NA
-
Collecting Solid Tumor Tissue to Identify New Treatments
NCT01658917 ·Status: COMPLETED
-
Circulating Tumor Cells (CTC) in Cancer
NCT04520672 ·Status: RECRUITING
-
Collection of Blood Specimens for Circulating Tumor Cell Analysis
NCT01943500 ·Status: COMPLETED
-
Feasibility Study of a Molecular Karyotype Using a Very High-throughput Sequencing Approach, the "Massive Parallel Sequencing" on Circulating Tumor DNA
NCT04104633 ·Status: COMPLETED ·Phase: NA
-
The Correlation Between Circulatory Tumor Cells and Venous Thrombosis
NCT06672250 ·Status: RECRUITING
-
Collection of Malignant Ascites, Pleural Fluid, and Blood From People With Solid Tumors
NCT03189108 ·Status: TERMINATED
-
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
NCT01137643 ·Status: RECRUITING
-
Development of a Novel Methodology Using BMVC Staining as an Assistance to Cancer Cytological Diagnosis
NCT01301690 ·Status: UNKNOWN
-
Genomic Sequencing in Determining Treatment in Patients With Metastatic Cancer or Cancer That Cannot Be Removed by Surgery
NCT02566421 ·Status: TERMINATED ·Phase: NA
-
Culture and Characterization of Circulating Tumor Cells (CTC) in Melanoma and Other Cancers
NCT01528774 ·Status: COMPLETED
-
Collection and Storage of Tissue Samples From Patients Undergoing Surgery For Suspected Solid Tumors
NCT00900471 ·Status: RECRUITING
-
Circulating Tumor Cells in Solid Tumors
NCT03161821 ·Status: COMPLETED
-
A Storage Facility for Tissues Obtained From Patients With Malignant Melanoma
NCT04567706 ·Status: RECRUITING
-
Sample Collection and Tracking for the Developmental Therapeutics Clinic
NCT03269578 ·Status: RECRUITING
-
Detecting Abnormal Blood Clotting in Patients With Metastatic Cancer Undergoing Surgery
NCT00096590 ·Status: COMPLETED
-
"Principle Test" for Isolation and Characterization of Circulating Cancer Cells (CTC)-CXCR4+.
NCT05818865 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Characterization of Circulating Tumor Cells Captured by c-MET (CTC-MET)
NCT02080650 ·Status: COMPLETED ·Phase: NA
-
A Pathology Reference Laboratory for the Study of Infectious Diseases and Malignant Lymphoma
NCT00266370 ·Status: UNKNOWN
-
Diagnosis of Multiple Cancer and Monitoring of Minimal Residual Tumors After Treatment Using Blood and High-Sensitivity Genetic Analysis Techniques
NCT07035587 ·Status: RECRUITING